Rheumatoid Arthritis: Developing Drug Products for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 31, 2013
April 23, 2020
f6725d58-9ccd-41cf-8684-52aca25cd029
Related Documents
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment: Draft Guidance for Industry
Guidance DocumentAugust 17, 2020Office of the Commissioner
Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials
Guidance DocumentApril 9, 2018Center for Drug Evaluation and Research
Investigational New Drug Applications Prepared and Submitted by Sponsor-Investigators
Guidance DocumentMay 15, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.